Biosimilars have the potential to greatly reduce US drug spending, but uptake of these competitors to single-source biologics varies a lot.
With @MeganFHyland in Health Affairs
Scholar, we investigate the role of direct-to-physician marketing in the transition to biosimilars.
Such an honor to participate in #JSIT2021 with @UWMadisonCFS. I learned best practices for developing research proposals, disseminating results, and everything in between. Looking forward to working with and learning from this talented cohort in the future!
And that's a wrap for the summer workshop portion of #JSIT2021! Congratulations to this year's cohort - we're looking forward to working with these scholars in the months and years to come: https://t.co/YclTGgtwoq